Cite

HARVARD Citation

    Kanjanapan, Y. et al. (2019). Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trials. European journal of cancer. pp. 1-7. [Online]. 
  
Back to record